Eosinophilic esophagitis;Esofagitis eosinofílica

Medicina Clinica

Volumn 128, Issue 15, 2007, Pages 590-597

  Lucendo, Alfredo J ^a,b  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^b NONE   (Spain)

Author keywords

Allergic esophagitis; Eosinophilic esophagitis; Eosinophilic gastrointestinal diseases; Gastrointestinal allergy

Indexed keywords

ALLERGEN; BECLOMETASONE; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; GLUCOCORTICOID; IMMUNOGLOBULIN E; INTERLEUKIN 5; MEPOLIZUMAB; METHYLPREDNISOLONE; NEDOCROMIL; PREDNISONE; STEROID;

ANTIGEN PRESENTATION; CELL ACTIVATION; CELL INFILTRATION; CELL TYPE; CELLULAR IMMUNITY; CLINICAL FEATURE; DEGRANULATION; DIET THERAPY; DISEASE CLASSIFICATION; DYSPHAGIA; ENDOSCOPIC THERAPY; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS MOTILITY; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MANOMETRY; MAST CELL; MORBIDITY; MOTOR DYSFUNCTION; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SENSITIZATION; TH1 CELL; TH2 CELL;

EID: 34249005604     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101616     Document Type: Review

References (111)

1. Cardona V, Guilarte M, Luengo O. Alergia a alimentos. Med Clin (Barc). 2006;126:424-30.
2. MacDonald TT, Pender SL. Lamina propria T cells. Chem Immunol. 1998;71:103-17.
3. MacDonal TT, Bajaj-Elliott M, Pender SL. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today. 1999;20:505-10.
4. Rothenberg ME. Eosinophilic gastrointestinal disorders. J Allergy Clin Inmunol. 2004;113:11-28.
5. De Keyser F, Elewaut D, De Wever N, Bensbaho K, Cuvelier C. The gut associated addressins: linphocyte homing in the gut. Baillieres Clin Rheumatol. 1996;10:25-39.
6. a ed. Madrid: Interamericana-McGraw-Hill; 1995.
7. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils in health and disease. Adv Immunol. 2001;78:291-328.
8. Butterworth AE. The eosinophil and its role in immunity to helminth infection. Curr Top Microbiol Immunol. 1997;77:127-68.
9. Butterworth AE. Cell-mediated damage to helminths. Adv Parasitol. 1984;23:143-235.
10. Weller PF, Lim K, Wan HC, Dvorak AM, Wong DT, Cruikshank WW, et al. Role of the eosinophil in allergic reactions. Eur Respir J. 1996; 22:109S-115S.
11. Adamko DJ, Odemuyiwa SO, Vethanayagan D, Moqbel R. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy. 2005;60:13-22.
12. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastroeintestinal eosinophils. Inmunol Rev. 2001;179:139-55.
13. Lucey DR, Nicholson WA, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA. 1989;86:1348-51.
14. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J, et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996;97:1761-76.
15. Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma) by immunoglobulin A complexes. J Exp Med. 1990;190:487-96.
16. Kita H. The eosinophil: a citokine producing cell? J Allergy Clin Immunol. 1996;97:889-92.
17. th ed. Philadelphia: Mosby; 2003. p. 305-32.
18. Sánchez-Fayos Calabuig P, Martín Reyoso MJ, González Guirado A, Porres Cubero JC. Los granulocitos eosinófilos: de residentes habituates de la mucosa gastrointestinal normal a protagonistas agresivos de la gastroenteritis eosinofilica. Gastroenterol Hepatol. 2006;29:352-7.
19. Furuta GT, Ackerman SJ, Wershil BK. The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol. 1995;11:541-7.
20. Yamazaki K, Murray JA, Arora AS, Alexander JA, Smyrk TC, Butterfield JH, et al. Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci. 2006;51:1934-41
21. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepitelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818-23.
22. Brown LF, Goldman H, Antonioli DA. Intraepitelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984;8:899-905.
23. Waldmann TA, Wochner RD, Laster L, Gordon RS Jr. Allergic gastroenteropathy. A cause of excesive gastrointestinal protein loss. N Engl J Med. 1967;276:762-9.
24. Klein NC, Hargrove RL, Sleisenger MH, Jeffries GH. Eosinophilic gastroenteritis. Medicine (Baltimore). 1970;49:299-319.
25. Dobbins JW. Eosinophilic gastroenteritis with esophageal involment Gastroenterology. 1977;72:1312.
26. Picus D, Frank P. Eosinophilic esophagitis. AJR Am J Roentgenol. 1981; 136:1001-3.
27. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophil with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993;38:109-16.
28. Spergel J, Rothenberg ME, Fogg M. Eliminating eosinophilic esophagitis. Clin Inmunol. 2005;115:131-2.
29. Lucendo AJ, Carrión G, Navarro M, Pascual JM, González P, Castillo P, et al. Eosinopilic esophagitis in adults: an emerging disease. Dig Dis Sci. 2004;49:1884-8.
30. Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc. 2002;56:260-70.
31. Straumann A, Beglinger C. Eosinophilic esophagitis: the endoscopist's enigma. Gastrointest Endosc. 2006;63:13-5.
32. Straumann A, Spichtin HP, Bucher KA, Heer P, Simon HU. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion 2004;70:109-16.
33. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adults patients for up to 11.5 years. Gastroenterology 2003; 125:1660-9.
34. Noel RJ, Putman PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;26:940-1.
35. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization Gastroenterology. 1992;102:1940-8.
36. Nunes GC, Ahlquist RE Jr. Increasing incidence of Crohn's disease Am J Surg. 1983;145:578-81.
37. Croese J, Fairley SK, Masson JW, Chong AKH, Whitaker DA, Kanowski PA, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516-22.
38. Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3-12.
39. Desai TK, Stecevic V, Chang C-H, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflamation with esophageal food impactation in adults. Gastrointest Endosc. 2005;61:795-801.
40. Lucendo Villarín AJ, Carrión Alonso G, Navarro Sánchez M, Martín Chávarri S, Gómez Senent S, Castillo Grau P, et al. Esofagitis eosinofílica, causa emergente de disfagia. Presentación de 9 casos. Rev Esp Enf Dig 2005;97:229-39.
41. Lucendo AJ, Navarro M, Comas C, Pascual JM, Burgos E, Santamaría L, et al. Immunophenotypic characterisation and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the disease's cellular mechanisms and the esophagus's immunological capacity. Am J Surg Pathol. En prensa 2007.
42. Lucendo AJ, Navarro M, Comas C, Letrán A, Pascual Turrión JM, Burgos, et al. Capacidad inmunológica del epitelio esofágico humano: estudio inmunofenotípico mediante estereología aplicado a la esofagitis eosinofílica [resumen]. Gastroenterol Hepatol. 2006;29:162.
43. Katz SI, Tamaki K, Sachs DH. Epitelial Langerhans cells originating in bone marrow. Nature. 1979;282:324-6.
44. Al Yassin TM, Toner PG. Langerhans cells in the human oesophagus J Anat. 1976;122:435-45.
45. Geboes K, De Wolf-Peeters C, Rutgeerts P, Janssens J, Vantrappen G Desmet V. Lymphocytes and Langerhans cells in the human oesophageal epithelium. Virchows Arch A Pathol Anat. 1983;401:45-55.
46. Teunissen MBM. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J. 1992;24:697-716.
47. Sontheimer RD, Stastny P, Núñez G. HLA-D region expression by human epidermal Langerhans cells. J Invest Dermatol. 1986;87:707-10.
48. Rowden G. Expression of la antigen on Langerhans cells in mice guinea pig and man. J Invest Dermatol. 1980;75:22-31.
49. Romagnani S, Parronchi O, D'Elios MM, Romagnani P, Annunciato F, Piccinni MP, et al. An update on human Th1 and Th2 cells. Int Arch Allergy Immunol. 1997;113:153-6.
50. Wang HH, Mangano MM, Antonioli A. Evaluation of T-lynfocites in esophageal mucosal biopsies. Mod Pathol. 1994;7:55-8.
51. Teitelbaum J, Fox V, Twarog F, Nurko S, Antonioli D, Badizadegan K, et al. Eosinophilic esophagitis in children: inmunopathological analysis' and response to fluticasone propionate. Gastroenterology 2002;122:1216-25.
52. Faubion WA, Perrault J, Burgart U, Zein NN, Clawson M, Furuta GT. Treatment of eosinophilic esophagitis with inhaled corticosteroids J Pediatr Gastroenterol Nutr. 1998;27:90-3.
53. Gleich GJ, Kita H. Bronchial astma: lessions from murine models. Proc Natl Acad Sci USA. 1997;94:2101-2.
54. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest. 1999;104;301-8.
55. Gharaee-Kermani M, McGarry B, Lukacs N, Huffnagle G, Egan RW, Phan SH. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol. 1998;64:657-66.
56. Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol. 2002;169:4604-12.
57. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83-90.
58. Gupta SK, Fitzgerald JF, Roudratynk T, Hogenesch H. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:22-6.
59. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflamatory response. J Allergy Clin Immunol. 2001;108:954-61.
60. Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism Gastroenterology. 2003;125:1419-27.
61. Gutiérrez Ramos JC, Lloyd C, Gonzalo JA. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today 1999;20:500-4.
62. Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg M. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest. 1999;103:1719-27.
63. Rothenberg M, Luster AD, Leder P. Murine eotaxina: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor supression. Proc Natl Acad Sci U S A. 1995;92:8960-4.
64. Zimmermann N, Hogan SP, Mishra A, Brandt EB, Bodette TR, Pope SM, et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol. 2000;165:5839-46.
65. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflamation. Natur Inmunol. 2001;2:353-60.
66. García-Zepeda EA, Rothenmberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophils cells and provides a new mechanism to explain tissue eosinophilia. Nature Med. 1996;2:449-56.
67. Lamkhioued B, Renzi PM, Abi-Younes S, García-Zepada EA, Allakhverdi Z, Ghaffar O, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997;159:4593-601.
68. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3) and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 1999;163:6321-9.
69. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536-47.
70. Furuta GT, Nieuwenhuis EE, Karhausen J, Gleich G, Blumberg RS, Lee JJ, et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol. 2005; 289:G890-G7.
71. Steiner SJ, Kernek KM, Fitzgerald JF. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:506-9.
72. Lim JR, Gupta SK, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR, et al. White specks in the esophageal mucosa: an endoscopic manifestation of non-reflux eosinophilic esophagitis in children. Gastrointest Endosc. 2004;59:835-8.
73. Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilc esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19:90-6.
74. Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hiperresponsiveness in primates. J Clin Invest. 1991;87:1470-3.
75. Lucendo AJ. Motor disturbances participate in the pathogenesis of eosinophilic oesophagistis, beyond the fibrous remodelling of the oesophagus. Aliment Pharmacol Ther. 2006;24:1264-7.
76. Lucendo AJ, Castillo P, Martín-Chávarri S, Carrión G, Pajares R, Pascual JM, et al. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur J Gastroenterol Hepatol. En prensa 2007.
77. O'Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med. 1983;157:1981-91.
78. Gonsalves N, Kagalwalla A, Kagalwalla A, Hess T, Li BU, Hirano I. Distinct features in the clinical presentations of eosinophilic esophagitis in children and adults [resumen]. Gastroenterology. 2005;128 Suppl 2:A-7.
79. Dauer EH, Freese DK, El-Youssef M, Thompson DM. Clinical characteristics of eosinophilic esophagitis in children. Ear Nose Throat J. 2005;114:827-33.
80. Gupta SP, Kirse DJ, Rostma GN, Belafsky PC. Eosinophilic esophagitis. Ear Nose Throat J. 2005;84:632-3.
81. Noel RJ, Putman PE, Collins MH, Assa'ad AH, Guajardo JR, Jameson SC, et al. Clinical and inmunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2: 568-75.
82. Sampson HA. Food allergy. JAMA. 1997;278:1888-94.
83. Dvorak AM, Onderdonk AB, McLeod RS, Monahan-Earley RA, Antonioli DA, Cullen J, et al. Ultraestructural indentification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol. 1993;102:33-45.
84. Martin ST, Collins CG, Fitzgibbon J, Lee G, Quigley EM, O'Sullivan GO. Gastric motor dysfunction: is eosinophilic mural gastritis a causative factor? Eur J Gastroenterol Hepatol. 2005;17:983-6.
85. Attwood SE. Eosinophilis and gut dysmotility. Eur J Gastroenterol Hepatol. 2005;17:891-2.
86. Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis (EE). A retrospective comparative pathologic biopsy study. J Clin Pathol. 2006;59:1175-80.
87. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Inmunol. 2003;112:796-7.
88. Onbasi K, Sin AZ, Doganavsalgil B, Onder GF, Bor S, Sebik F. Eosinophil infiltration of the esophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy. 2005;35:1423-31.
89. Akei HS, Mishra A, Blanchard C, Rothenberg ME. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 2005;129:985-94.
90. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Inmunol. 2002;109:363-8.
91. Sampson HA. Update in food allergy. J Allergy Clin Immunol. 2004;113-813-9
92. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151-60.
93. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific elimination diet directed by a combination of skin prick and patch test. Ann Allergy Asthma Immunol. 2005;95:336-43.
94. Assa'ad A. Detection of causative foods by skin prick and atopy patch test in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol. 2005;95:309-11.
95. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198-206.
96. Bishop WP, Haber BA, Lichtman SN, Shneider BL. Learning more about eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2002;35:711-2.
97. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503-12.
98. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98:777-82.
99. Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children:successful tratment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380-5.
100. Bory F, Vázquez E, Forcada P, Viver JM, Andreu M. Esofagitis eosinofilica como causa de disfagia de 10 años de evolution. Gastroenterol Hepatol. 1998;21:287-8.
101. Perrault J, Arora AS, Clawson ML, Smyrk TC. Treatment of eosinophilic esophagitis with steoid lavage in adult patients [resumen]. Am J Gastroenterol. 2001;96:S31.
102. Martín-Muñoz MF, Lucendo AJ, Navarro M, Letrán A, Martín-Chávarri S, Burgos E, et al. Food allergy and eosinophilic esophagitis: two cases studies. Digestion. 2006;74:49-54.
103. Whelan GJ, Blumer JL, Martin RJ, Szefler SJ. Fluticasone propionate plasma concentration and systemis effect: effect of delivery devide and duration of administration. J Allergy Clin Immunol. 2005;116:525-30.
104. Aceves SS, Dohil R, Newbury RO, Bastian JF. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2005;116:705-6.
105. Moots RJ, Prouse P, Gumpel JM. Near fatal eosinophilic gastroenteritis responded to oral sodium cromoglycate. Gut. 1988;29:1282-5.
106. Shirai T, Hashimoto D, Suzuki K, Osawa S, Aonahata M, Chida K, et al. Successful treatment of eosinophilic esophagitis gastroenteritis with suplatast tosilate. J Allergy Clin Inmunol. 2001;107:924-5.
107. Neustrom MR, Friesen C. Treatment of eosinophilic gastroenteritis with montelukast [carta]. J Allergy Clin Inmunol. 1999;104:506.
108. Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic esophagitis: a novel treatment using montelukast. Gut. 2003;52:181-5.
109. Kim YJ, Prussin C, Martin B, Law MA, Haverty TP, Nutman TB, et al. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700. J Allergy Clin Inmunol. 2004;114:1449-55.
110. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, et al. Anti-interluekin-5 (mepolizumab) therapy for hipereosinophilic syndromes. J Allergy Clin Inmunol. 2003;113:115-9.
111. Zuber-Jerger I, Ratiu N, Kullman F. Long-lasting effect of endoscopic dilation of an esophageal stenosis due to eosinophilic esophagitis. J Gastrointestin Liver Dis. 2006;15:167-70.